Relay Therapeutics, Inc. RLAY Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s enterprise value?
- Relay Therapeutics, Inc. (RLAY) reported enterprise value of $1.61B in Q1 2026.
- How has Relay Therapeutics, Inc.'s enterprise value changed year-over-year?
- Relay Therapeutics, Inc.'s enterprise value increased by 303.6% year-over-year, from $397.76M to $1.61B.
- What is the long-term trend for Relay Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s enterprise value has grown at a -15.7% compound annual growth rate (CAGR), from $3.33B to $1.41B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.